查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1771297

生物製程自動化市場：產業趨勢及全球預測 - 依控制器類型、業務規模、操作模式、與生物處理系統的兼容性、主要地區

Bioprocess Automation Market: Industry Trends and Global Forecasts - Distribution by Type of Controller, Scale of Operation, Mode of Operation, Compatibility with Bioprocessing Systems, and Key Geographical Regions
出版日期: | 出版商: Roots Analysis | 英文 237 Pages | 商品交期: 最快1-2個工作天內

價格

全球生物過程自動化市場：概覽

全球生物製程自動化市場規模目前約 38億美元。預計市場在預測期內的年複合成長率為 12%。

市場規模與機會分析依下列參數細分：

控制器類型

  • 上游/下游控制器系統
  • 生物過程控制軟體

企業規模

  • 臨床前/臨床運營
  • 商業運營

操作模式

  • 批量/補料分批生產
  • 灌注生產

與生物製程系統相容

  • 一次性系統
  • 不銹鋼/其他系統

主要地區

  • 北美
  • 歐洲
  • 亞太地區及其他地區世界

全球生物過程自動化市場：成長與趨勢

近幾十年來，生物製藥因其療效顯著、安全性高以及能夠治療多種複雜疾病而日益受到青睞。生物製藥治療的成功促使眾多利害關係人對生物製造中使用的傳統設備進行現代化改造。值得注意的是，生物製程控制器和自動化系統克服了傳統生物反應器系統的不足，成為生物製藥產業的製程最佳化解決方案。此外，這些控制器和自動化系統利用製程分析技術工具，可無縫整合到生物製程設備中，提高可擴展性。

生物過程自動化市場-IMG1

此外，新冠疫情期間生物製劑需求的增加，也導致上述系統的採用率激增。因此，一些生物製程設備開發商增加了受控自動化系統的產品線，目的是提高生產力、縮短生產時間、降低產品成本並增強生物製程的靈活性。

全球生物過程自動化市場：關鍵洞察

本報告深入探討了全球生物過程自動化市場的現狀，並識別了該行業的潛在成長機會。報告的主要調查結果包括：

  • 全球不同地區的多家公司提供/開發超過120種生物製程控制器和自動化系統。
  • 超過40%的生物製程控制器和自動化系統用於下游製程最佳化，其次是近30%的控制器用於上游製程最佳化。
生物過程自動化市場-IMG2
  • 該領域的特點是近40%的小型企業佔據主導地位，其中超過30%的企業開發用於上游製程的控制器。此外，超過50%的生物製程控制器和自動化系統供應商位於歐洲。
  • 目前的市場格局較為分散，既有老牌企業，也有新進者。
  • 成立於1970年之前的生物製程控制器和自動化系統供應商（依字母排列）主要包括Cytiva、Eppendorf、Merck、Parker Hannifin、Sartorius Stedim Biotech和Thermo Fisher Scientific。
  • 總部位於歐洲的開發商中，超過40%是中小企業，其中近75%位於德國、法國和瑞士。
  • 超過65%的生物製程控制器和自動化系統由知名/老牌企業提供，其中57%的參與者聲稱同時提供細胞培養和微生物發酵系統。
  • 為了獲得競爭優勢，生物製程控制器開發商目前正致力於將高階功能整合到各自的產品中。
  • 工業界和非工業界已提交/授予近3,500項與生物製程控制器和自動化技術相關的專利，顯示該領域的創新步伐加快。
  • 有相當一部分的專利是在北美提交/授予（約65%），主要專利權人包括GE Healthcare/Cytiva、Cytori Therapeutics、Xyleco、Inscripta、Lonza和Terumo BCT。
  • 為了滿足日益成長的生物製程自動化需求，許多利害關係人著手實施技術先進的系統。
  • 鑑於生物製程控制器和自動化系統在減少人為錯誤和降低製程成本方面的潛力，其應用可能會增加；預計相關市場在預測期內的年複合成長率將達到12%。
生物過程自動化市場-IMG3

全球生物過程自動化市場：關鍵細分市場

依業務規模，市場分為臨床前/臨床及商業領域。目前，臨床前/臨床營運領域在全球生物過程自動化市場中佔有最大佔有率（約75%）。預計未來這一趨勢將保持不變。

依控制器類型，市場分為上下游控制器系統和生物製程控制軟體。目前，上下游控制器系統領域在生物製程自動化市場中佔有最大佔有率（約60%）。

歐洲佔最大市場佔有率

根據主要地區，市場細分為北美、歐洲、亞太地區和世界其他地區。目前，歐洲（超過 40%）在生物過程自動化市場佔據主導地位，佔據最大的收入佔有率。

生物過程自動化市場參與者

  • Applikon Biotechnology
  • Cytiva
  • Repligen
  • Sartorius
  • Sepragen
  • Solaris Biotech
  • Sysbiotech
  • Thermo Fisher Scientific

本報告調查全球生物製程自動化市場，提供市場概述，以及依控制器類型、企業規模、操作模式、與生物處理系統的兼容性、依地區劃分的趨勢以及參與市場的公司簡介。

目錄

第1章 前言

第2章 執行摘要

第3章 簡介

  • 章節概述
  • 生物過程控制
  • 過程控制的組成部分
  • 製程控制的目標
  • 生物過程自動化
  • 生物過程自動化的優勢
  • 自動化控制的挑戰
  • 生物過程控制的突破
  • 未來展望

第4章 市場格局：上游控制器

  • 章節概述
  • 上游控制器：產品線
  • 上游控制器：開發者格局

第5章 市場市場格局：下游控制器系統

  • 章節概述
  • 下游控制器系統：產品線
  • 下游控制器系統：開發商格局

第6章 市場格局：生物製程控制軟體

  • 章節概述
  • 生物製程控制軟體：產品線
  • 生物製程控制軟體：開發商格局

第7章 產品競爭力分析

  • 章節概述
  • 研究方法
  • 假設/關鍵參數
  • 產品競爭力分析：上游控制器
  • 產品競爭力分析：下游控制器系統
  • 產品競爭力分析：生物製程控制器軟體

第8章 北美生物製程控制器與自動化系統開發商：公司簡介

  • 章節概述
  • Cytiva Lifesciences
  • Thermo Fisher Scientific
  • Sepragen
  • Repligen

第9章 歐洲生物過程控制器與自動化系統開發商：公司簡介

  • 章節概述
  • Applikon Biotechnology
  • Sartorius
  • Solaris Biotech
  • Sysbiotech

第10章 市場趨勢分析

  • 章節概述
  • 世界地圖圖示：依總部位置和產品類型分析參與者
  • 市場趨勢分析：上游控制器
  • 市場趨勢分析：下游控制器系統
  • 市場趨勢分析：生物製程控制軟體

第11章 專利分析

  • 章節概述
  • 研究範圍與方法
  • 生物製程控制器與自動化系統：專利分析
  • 專利基準分析
  • 生物製程控制器與自動化系統：專利估值分析
  • 引用次數最高的專利

第12章 品牌定位分析

  • 章節概述
  • 研究方法
  • 關鍵參數
  • 上游控制器開發商的品牌定位矩陣
  • 下游控制系統開發商的品牌定位矩陣
  • 生物製程控制器軟體開發商的品牌定位矩陣

第13章 市場預測與機會分析

  • 章節概述
  • 預測研究方法與關鍵假設
  • 2035年生物製程控制器與自動化市場整體規模
  • 2035年生物製程控制器與自動化市場（依控制器類型）
  • 2035年生物製程控制器與自動化市場（依企業規模）
  • 2035年生物製程控制器與自動化市場（依操作模式）
  • 2035年生物製程控制器與自動化市場（依系統類型）
  • 2035年生物製程控制器與自動化市場（依主要區域）

第14章 結論

第15章 高層洞察

第16章 附錄1：表格資料

第17章 附錄2：公司與組織清單

Product Code: RA100298

GLOBAL BIOPROCESS AUTOMATION MARKET: OVERVIEW

As per Roots Analysis, the bioprocess automation market valued at USD 3.8 billion in the current year is anticipated to grow at a CAGR of 12% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Controller

  • Upstream / Downstream Controller System
  • Bioprocess Control Software

Scale of Operation

  • Preclinical / Clinical Operation
  • Commercial Operation

Mode of Operation

  • Batch / Fed-Batch Manufacturing
  • Perfusion Manufacturing

Compatibility with Bioprocessing Systems

  • Single-Use Systems
  • Stainless Steel / Other Systems

Key Geographical Regions

  • North America
  • Europe
  • Asia-Pacific and Rest of the World

GLOBAL BIOPROCESS AUTOMATION MARKET: GROWTH AND TRENDS

In recent decades, biopharmaceuticals have become increasingly popular due to their therapeutic effectiveness, favorable safety profiles, and capacity to address a wide range of complex diseases. The success of treatments with the use of biopharmaceuticals has encouraged several stakeholders to modernize traditional equipment used for biological manufacturing. Notably, the bioprocess controllers and automation systems have turned out to be a process optimization solution for the biopharmaceutical industries, overcoming the inadequacy of the traditional bioreactor systems. Moreover, these controllers and automated systems utilize process analytical technology tools that can be seamlessly integrated into bioprocessing units to enhance scalability.

Bioprocess Automation Market - IMG1

Further, amidst the COVID-19 pandemic, the increasing demand for biologics has led to the surge in the adoption rate of the aforementioned systems. As a result, several bioprocess equipment developers increased their controlled and automated systems offerings in order to increase productivity, shorten production timelines, reduce cost of goods, and increase flexibility of the bioprocess.

GLOBAL BIOPROCESS AUTOMATION MARKET: KEY INSIGHTS

The report delves into the current state of global bioprocess automation market and identifies potential growth opportunities within industry. Some key findings from the report include:

  • Over 120 bioprocess controllers and automation systems are available / being developed by various companies based in different regions across the globe; majority of the controllers are designed for upstream processes.
  • Over 40% of the bioprocess controllers and automation systems are being offered to optimize the downstream processes, followed by nearly 30% controllers, which are used to optimize upstream processes.
Bioprocess Automation Market - IMG2
  • The domain is featured by the presence of nearly 40% small players; of which, over 30% of players are developing upstream controllers. Further, more than 50% of these players offering bioprocess controllers and automation systems are based in Europe.
  • The current market landscape is fragmented, featuring the presence of both established players and new entrants; most of the companies are headquartered in developed nations.
  • Prominent examples of bioprocess controllers and automated system providers established before 1970 (in alphabetical order) include Cytiva, Eppendorf, Merck, Parker Hannifin, Sartorius Stedim Biotech and Thermo Fisher Scientific.
  • More than 40% developers headquartered in Europe are small and mid-sized players; of these, close to 75% companies are located in Germany, France, and Switzerland.
  • Over 65% of bioprocess controllers and automation systems are offered by known / established players; of these, 57% of the stakeholders claim to offer systems for both cell cultivation and microbial fermentation.
  • In pursuit of gaining a competitive edge, bioprocess controller developers are presently focusing on the integration of advanced features into their respective products.
  • Close to 3,500 patents related to bioprocess controller and automation technologies have been filed / granted to industry and non-industry players, indicating the enhanced pace of innovation in this field.
  • A significant proportion of patents have been filed / granted in North America (~65%); key patent assignees include GE Healthcare / Cytiva, Cytori Therapeutics, Xyleco, Inscripta, Lonza, and Terumo BCT.
  • Over time, several stakeholders have established strong brand positions; in order to cater to increasing demand for bioprocess automation, a number of players have stepped up to introduce technologically advanced systems.
  • Given the potential to reduce human errors and process costs, the adoption of bioprocess controllers and automation systems is likely to increase; the affiliated market is expected to grow at a CAGR of 12% during the forecast period.
Bioprocess Automation Market - IMG3

GLOBAL BIOPROCESS AUTOMATION MARKET: KEY SEGMENTS

Preclinical / Clinical Segment Occupies the Largest Share of the Bioprocess Automation Market

Based on the scale of operation, the market is segmented into preclinical / clinical operations and commercial operations. At present, preclinical / clinical operations segment holds the maximum (~75%) share of the global bioprocess automation market. This trend is likely to remain same in the coming future.

By Type of Controller, Upstream / Downstream Controller System Segment Accounts for the Largest Share in the Bioprocess Automation Market

Based on the type of controller, the market is segmented into upstream / downstream controller system and bioprocess control software. Currently, upstream / downstream controller system segment captures the highest proportion (~60%) of the bioprocess automation market.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, and Asia-Pacific and Rest of the World. Currently, Europe (>40%) dominates the bioprocess automation market and accounts for the largest revenue share.

Example Players in the Bioprocess Automation Market

  • Applikon Biotechnology
  • Cytiva
  • Repligen
  • Sartorius
  • Sepragen
  • Solaris Biotech
  • Sysbiotech
  • Thermo Fisher Scientific

GLOBAL BIOPROCESS AUTOMATION MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global bioprocess automation market, focusing on key market segments, including [A] type of controller, [B] scale of operation, [C] mode of operation, [D] compatibility with bioprocessing systems and [E] key geographical regions.
  • Market Landscape: A comprehensive evaluation of bioprocess controllers and automation systems, considering various parameters, such as [A] scale of operation, [B] mode of operation, [C] key features, [D] compatibility with the bioprocessing systems, [E] type of system(s) and [F] type of processes controlled. Additionally, a comprehensive analysis of the companies developing bioprocess controllers and automation systems, based on [A] year of establishment, [B] company size, and [C] geographical presence.
  • Product Competitiveness Analysis: A comprehensive competitive analysis of upstream controllers, downstream controller systems and process control software, examining factors, such as [A] product applicability and [B] product strength.
  • Company Profiles: In-depth profiles companies providing upstream controllers, downstream controller systems and process control software, focusing on [A] company overview, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
  • Key Insights: In-depth analysis of market trends, focusing on [A] regional distribution of players and [B] type of products offered. Additionally, a [C] distribution of upstream controllers, based on compatibility with bioreactor systems, scale of operation and mode of operation, [D] an analysis of upstream controllers, based on scale of operation, compatibility with bioreactor systems and processes controlled [E] an analysis of downstream controller systems, based on scale of operation, type of systems and key features, [F] an analysis of downstream controller systems, based on mode of operation and application area [G] an analysis of bioprocess control software, based on scale of operation, key features and processes controlled and [H] an analysis of bioprocess control software, based on scale of operation and compatibility with bioprocessing systems.
  • Patent Analysis: An insightful analysis of various patents that have been filed / granted for bioprocess controllers and automation systems, based on several parameters, such as [A] type of patents, [B] publication year, [C] application year, [D] issuing authorities involved, [E] type of organizations, [F] emerging focus area, [G] patent age, [H] CPC symbols, [I] leading patent assignees (in terms of number of patents granted / filed), [J] patent characteristics, [K] geography, [L] patent benchmarking and [M] an insightful valuation analysis.
  • Brand Positioning Analysis: In-depth analysis of brand positioning of the key industry players, highlighting the current perceptions regarding their proprietary products based on several relevant factors, such as [A] experience of the manufacturer, [B] number of products offered, [C] product diversity and [D] number of patents published.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with Research Team
  • Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
    • 1.2.1. Research Assumptions
    • 1.2.2. Project Methodology
    • 1.2.3. Forecast Methodology
    • 1.2.4. Robust Quality Control
    • 1.2.5. Key Considerations
      • 1.2.5.1. Demographics
      • 1.2.5.2. Economic Factors
      • 1.2.5.3. Government Regulations
      • 1.2.5.4. Supply Chain
      • 1.2.5.5. COVID Impact / Related Factors
      • 1.2.5.6. Market Access
      • 1.2.5.7. Healthcare Policies
      • 1.2.5.8. Industry Consolidation
  • 1.3 Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Bioprocess Control
  • 3.3. Building Block of Process Control
    • 3.3.1. Components of Process Control Systems
      • 3.3.1.1. Sensors
      • 3.3.1.2. Actuators
      • 3.3.1.3. Controllers
  • 3.4. Purpose of Process Control
  • 3.5. Bioprocess Automation
  • 3.6. Advantages of Bioprocess Automation
  • 3.7. Challenges Faced in Automated Control
    • 3.7.1. Process Related Challenges to Automate
    • 3.7.2. Compatibility and Infrastructure Challenges
    • 3.7.3. Regulatory Challenges
    • 3.7.4. IT Concerns and Data Integrity
  • 3.8. Breakthrough in Bioprocess Control
    • 3.8.1. Flexible and Automated Skids
    • 3.8.2. Spectroscopy
    • 3.8.3. Multivariate data Analytics
  • 3.9. Future Perspective

4. MARKET LANDSCAPE: UPSTREAM CONTROLLERS

  • 4.1. Chapter Overview
  • 4.2. Upstream Controllers: Product Pipeline
    • 4.2.1. Analysis by Scale of Operation
    • 4.2.2. Analysis by Key Features
    • 4.2.3. Analysis by Compatibility with Bioreactor System
    • 4.2.4. Analysis by Mode of Operation
    • 4.2.5. Analysis by Types of Processes Controlled
  • 4.3. Upstream Controllers: Developer Landscape
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Location of Headquarters
    • 4.3.4. Leading Developers: Analysis by Number of Upstream Controllers

5. MARKET LANDSCAPE: DOWNSTREAM CONTROLLER SYSTEMS

  • 5.1. Chapter Overview
  • 5.2. Downstream Controller Systems: Product Pipeline
    • 5.2.1. Analysis by Scale of Operation
    • 5.2.2. Analysis by Key Features
    • 5.2.3. Analysis by Types of Systems Involved
    • 5.2.4. Analysis by Mode of Operation
    • 5.2.5. Analysis by Application Area
  • 5.3. Downstream Controller Systems: Developer Landscape
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters
    • 5.3.4. Leading Developers: Analysis by Number of Products

6. MARKET LANDSCAPE: BIOPROCESS CONTROL SOFTWARE

  • 6.1. Chapter Overview
  • 6.2. Bioprocess Control Software: Product Pipeline
    • 6.2.1. Analysis by Stage of Bioprocess
    • 6.2.2. Analysis by Scale of Operation
    • 6.2.3. Analysis by Key Features
    • 6.2.4. Analysis by Compatibility with Systems
    • 6.2.5. Analysis by Types of Processes Controlled
  • 6.3. Bioprocess Control Software: Developer Landscape
    • 6.3.1. Analysis by Year of Establishment
    • 6.3.2. Analysis of Company Size
    • 6.3.3. Analysis by Location of Headquarters
    • 6.3.4. Leading Developers: Analysis by Number of Bioprocess Control Software

7. PRODUCT COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Methodology
  • 7.3. Assumptions / Key Parameters
  • 7.4. Product Competitiveness Analysis: Upstream Controllers
  • 7.5. Product Competitiveness Analysis: Downstream Controller Systems
  • 7.6. Product Competitiveness Analysis: Bioprocess Controller Software

8. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN NORTH AMERICA: COMPANY PROFILES

  • 8.1. Chapter Overview
  • 8.2. Cytiva Lifesciences
    • 8.2.1. Company Overview
    • 8.2.2. Bioprocess Controller and Automation System Portfolio
    • 8.2.3. Recent Developments and Future Outlook
  • 8.3. Thermo Fisher Scientific
    • 8.3.1. Company Overview
    • 8.3.2. Bioprocess Controller and Automation System Portfolio
    • 8.3.3. Recent Developments and Future Outlook
  • 8.4. Sepragen
    • 8.4.1. Company Overview
    • 8.4.2. Bioprocess Controller and Automation System Portfolio
    • 8.4.3. Recent Developments and Future Outlook
  • 8.5. Repligen
    • 8.5.1. Company Overview
    • 8.5.2. Bioprocess Controller and Automation System Portfolio
    • 8.5.3. Recent Developments and Future Outlook

9. BIOPROCESS CONTROLLER AND AUTOMATION SYSTEM DEVELOPERS IN EUROPE: COMPANY PROFILES

  • 9.1. Chapter Overview
  • 9.2. Applikon Biotechnology
    • 9.2.1. Company Overview
    • 9.2.2. Bioprocess Controller and Automation System Portfolio
    • 9.2.3. Recent Developments and Future Outlook
  • 9.3. Sartorius
    • 9.3.1. Company Overview
    • 9.3.2. Bioprocess Controller and Automation System Portfolio
    • 9.3.3. Recent Developments and Future Outlook
  • 9.4. Solaris Biotech
    • 9.4.1. Company Overview
    • 9.4.2. Bioprocess Controller and Automation System Portfolio
    • 9.4.3. Recent Developments and Future Outlook
  • 9.5. Sysbiotech
    • 9.5.1. Company Overview
    • 9.5.2. Bioprocess Controller and Automation System Portfolio
    • 9.5.3. Recent Developments and Future Outlook

10. MARKET TREND ANALYSIS

  • 10.1. Chapter Overview
  • 10.2. World Map Representation: Analysis of Players by Location of Headquarters and Type of Product(s) Offered
  • 10.3. Market Trend Analysis: Upstream Controllers
    • 10.3.1. Heat Map Representation: Analysis by Scale of Operation, Compatibility with Bioreactor Systems and Operating Mode
    • 10.3.2. Grid Analysis: Analysis by Scale of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
  • 10.4. Market Trend Analysis: Downstream Controller Systems
    • 10.4.1. Grid Analysis: Analysis by Scale of Operation, Type of System(s) and Key Features
    • 10.4.2. Analysis by Operation Mode and Application Area
  • 10.5. Market Trend Analysis: Bioprocess Control Software
    • 10.5.1. Grid Analysis: Analysis by Scale of Operation, Key Features and Types of Processes Controlled
    • 10.5.2. Analysis by Scale of operation and Compatibility with Systems

11. PATENT ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Scope and Methodology
  • 11.3. Bioprocess Controller and Automations Systems: Patent Analysis
    • 11.3.1. Analysis by Publication Year
    • 11.3.2. Analysis by Application Year
    • 11.3.3. Analysis by Patent Office
    • 11.3.4. Analysis by Geographical Location
    • 11.3.5. Analysis by CPC Symbols
    • 11.3.6. Emerging Focus Area
    • 11.3.7. Analysis by Type of Organization
    • 11.3.8. Leading Players: Analysis by Number of Patents
  • 11.4. Patent Benchmarking Analysis
    • 11.4.1. Analysis by Patent Characteristics
  • 11.5. Bioprocess Controller and Automations Systems: Patent Valuation Analysis
  • 11.6. Leading Patents by Number of Citations

12. BRAND POSITIONING ANALYSIS

  • 12.1. Chapter Overview
  • 12.2. Methodology
  • 12.3. Key Parameters
  • 12.4. Brand Positioning Matrix of Upstream Controller Developers
    • 12.4.1. Brand Positioning Matrix: Applikon Biotechnology
    • 12.4.2. Brand Positioning Matrix: Eppendorf
    • 12.4.3. Brand Positioning Matrix: Thermo Fisher Scientific
    • 12.4.4. Brand Positioning Matrix: ILS Automation
    • 12.4.5. Brand Positioning Matrix: Pierre Guerin
  • 12.5. Brand Positioning Matrix of Downstream Controller System Developers
    • 12.5.1. Brand Positioning Matrix: Cytiva Lifesciences
    • 12.5.2. Brand Positioning Matrix: Sepragen
    • 12.5.3. Brand Positioning Matrix: Merck Millipore
    • 12.5.4. Brand Positioning Matrix: Sartorius Stedim Biotech
    • 12.5.5. Brand Positioning Matrix: Repligen
    • 12.5.6. Brand Positioning Matrix: Agilitech
  • 12.6. Brand Positioning Matrix of Bioprocess Controller Software Developers
    • 12.6.1. Brand Positioning Matrix: Applikon Biotechnology
    • 12.6.2. Brand Positioning Matrix: Pierre Guerin
    • 12.6.3. Brand Positioning Matrix: Thermo Fisher Scientific
    • 12.6.4. Brand Positioning Matrix: Merck Millipore
    • 12.6.5. Brand Positioning Matrix: Sartorius Stedim Biotech
    • 12.6.6. Brand Positioning Matrix: Cytiva Lifesciences
    • 12.6.7. Brand Positioning Matrix: Bionet Engineering

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 13.1. Chapter Overview
  • 13.2. Forecast Methodology and Key Assumptions
  • 13.3. Overall Bioprocess Controller and Automation Market, Till 2035
  • 13.4. Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Controller
    • 13.4.1. Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, Till 2035
    • 13.4.2. Bioprocess Controller and Automation Market for Bioprocess Control Software, Till 2035
  • 13.5. Bioprocess Controller and Automation Market, Till 2035: Distribution by Scale of Operation
    • 13.5.1. Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, Till 2035
    • 13.5.2. Bioprocess Controller and Automation Market for Commercial Operations, Till 2035
  • 13.6. Bioprocess Controller and Automation Market, Till 2035: Distribution by Mode of Operation
    • 13.6.1. Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, Till 2035
    • 13.6.2. Bioprocess Controller and Automation Market for Perfusion Manufacturing, Till 2035
  • 13.7. Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Systems
    • 13.7.1. Bioprocess Controller and Automation Market for Single-use Systems, Till 2035
    • 13.7.2. Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, Till 2035
  • 13.8. Bioprocess Controller and Automation Market, Till 2035: Distribution by Key Geographical Regions
    • 13.8.1. Bioprocess Controller and Automation Market in North America, Till 2035
    • 13.8.2. Bioprocess Controller and Automation Market in Europe, Till 2035
    • 13.8.3. Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, Till 2035

14. CONCLUSION

  • 14.1. Chapter Overview

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 4.1 Upstream Controllers: Information on Dimensions and Scale of Operation
  • Table 4.2 Upstream Controllers: Information on Key Features, Mode of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
  • Table 4.3 Upstream Controller Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 5.1 Downstream Controller Systems: Information on Dimensions, Type of Controllers and Scale of Operation
  • Table 5.2 Downstream Controller Systems: Information on Key Features, Type of Bioprocessing System(s) Involved, Mode of Operation and Application Area
  • Table 5.3 Downstream Controller System Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 6.1 Bioprocess Control Software: Information on Stage of Bioprocess and Scale of Operation
  • Table 6.2 Bioprocess Control Software: Information on Key Features, Compatibility with Bioprocessing Systems and Types of Processes Controlled
  • Table 6.3 Bioprocess Control Software Developers: Information of Year of Establishment, Company Size and Location of Headquarters
  • Table 8.1 Bioprocess Controllers and Automation: List of Companies Profiled
  • Table 8.2 Cytiva Lifesciences: Company Snapshot
  • Table 8.3 Cytiva Lifesciences: Product Portfolio (Downstream Controller Systems)
  • Table 8.4 Cytiva Lifesciences: Product Portfolio (Bioprocess Control Software)
  • Table 8.5 Cytiva Lifesciences: Recent Developments and Future Outlook
  • Table 8.6 Thermo Fisher Scientific: Company Snapshot
  • Table 8.7 Thermo Fisher Scientific: Product Portfolio (Upstream Controllers)
  • Table 8.8 Thermo Fisher Scientific: Product Portfolio (Bioprocess Control Software)
  • Table 8.9 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 8.10 Sepragen: Company Snapshot
  • Table 8.11 Sepragen: Product Portfolio (Downstream Controller Systems)
  • Table 8.12 Repligen Corporation: Company Snapshot
  • Table 8.13 Repligen: Product Portfolio (Downstream Controller Systems)
  • Table 8.14 Repligen Corporation: Recent Developments and Future Outlook
  • Table 9.1 Bioprocess Controllers and Automation: List of Companies Profiled
  • Table 9.2 Applikon Biotechnology: Company Snapshot
  • Table 9.3 Applikon Biotechnology: Product Portfolio (Upstream Controllers)
  • Table 9.4 Applikon Biotechnology: Product Portfolio (Bioprocess Control Software)
  • Table 9.5 Applikon biotechnology: Recent Developments and Future Outlook
  • Table 9.6 Sartorius: Company Snapshot
  • Table 9.7 Sartorius: Product Portfolio (Upstream Controllers)
  • Table 9.8 Sartorius: Product Portfolio (Downstream Controller Systems)
  • Table 9.9 Sartorius: Product Portfolio (Bioprocess Control Software)
  • Table 9.10 Sartorius: Recent Developments and Future Outlook
  • Table 9.11 Solaris Biotech: Company Snapshot
  • Table 9.12 Solaris Biotech: Product Portfolio (Upstream Controllers)
  • Table 9.13 Solaris Biotech: Product Portfolio (Downstream Controller Systems)
  • Table 9.14 Solaris Biotech: Product Portfolio (Bioprocess Control Software)
  • Table 9.15 Solaris Biotech: Recent Developments and Future Outlook
  • Table 9.16 Sysbiotech: Company Snapshot
  • Table 9.17 Sysbiotech: Product Portfolio (Upstream Controllers)
  • Table 9.18 Sysbiotech: Recent Developments and Future Outlook
  • Table 11.1 Patent Analysis: Prominent CPC Symbols
  • Table 11.2 Patent Analysis: List of Top CPC Symbols
  • Table 11.3 Patent Analysis: Leading CPC Symbol Definitions
  • Table 11.4 Patent Analysis: Summary of Benchmarking Analysis
  • Table 11.5 Patent Analysis: Categorization based on Weighted Valuation Scores
  • Table 11.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
  • Table 11.7 Patent Portfolio: List of Leading Patents (by Number of Citations)
  • Table 16.1 Upstream Controllers: Distribution by Scale of Operation
  • Table 16.2 Upstream Controllers: Distribution by Key Features
  • Table 16.3 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
  • Table 16.4 Upstream Controllers: Distribution by Mode of Operation
  • Table 16.5 Upstream Controllers: Distribution by Types of Processes Controlled
  • Table 16.6 Upstream Controller Developers: Distribution by Year of Establishment
  • Table 16.7 Upstream Controller Developers: Distribution by Company Size
  • Table 16.8 Upstream Controller Developers: Distribution by Location of Headquarters
  • Table 16.9 Leading Developers: Distribution by Number of Products
  • Table 16.10 Downstream Controller Systems: Distribution by Scale of Operation
  • Table 16.11 Downstream Controller Systems: Distribution by Key Features
  • Table 16.12 Downstream Controller Systems: Distribution by Type of Bioprocessing System(s)
  • Table 16.13 Downstream Controller Systems: Distribution by Mode of Operation
  • Table 16.14 Downstream Controller Systems: Distribution by Application Area
  • Table 16.15 Downstream Controller System Developers: Distribution by Year of Establishment
  • Table 16.16 Downstream Controller System Developers: Distribution by Company Size
  • Table 16.17 Downstream Controller System Developers: Distribution by Location of Headquarters
  • Table 16.18 Leading Developers: Distribution by Number of Products
  • Table 16.19 Bioprocess Control Software: Distribution by Stage of Bioprocess
  • Table 16.20 Bioprocess Control Software: Distribution by Scale of Operation
  • Table 16.21 Bioprocess Control Software: Distribution by Key Features
  • Table 16.22 Bioprocess Control Software: Distribution by Compatibility with Bioprocessing Systems
  • Table 16.23 Bioprocess Control Software: Distribution by Types of Processes Controlled
  • Table 16.24 Bioprocess Control Software Developers: Distribution by Year of Establishment
  • Table 16.25 Bioprocess Control Software Developers: Distribution by Company Size
  • Table 16.26 Bioprocess Control Software Developers: Distribution by Location of Headquarters
  • Table 16.27 Leading Developers: Distribution by Number of Products
  • Table 16.28 Downstream Controller System: Distribution by Operating Mode and Application Area
  • Table 16.29 Bioprocess Control Software: Distribution by Scale of Operation and Compatibility with Systems
  • Table 16.30 Patent Analysis: Distribution by Type of Patent
  • Table 16.31 Patent Analysis: Cumulative Distribution by Publication Year, Since Pre-2015
  • Table 16.32 Patent Analysis: Distribution by Application Year, Since Pre-2015
  • Table 16.33 Patent Analysis: Distribution by Patent Office
  • Table 16.34 Patent Analysis: Distribution by Geographical Location
  • Table 16.35 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
  • Table 16.36 Patent Analysis: Leading Industry Players
  • Table 16.37 Patent Analysis: Leading Non-Industry Players
  • Table 16.38 Patent Analysis: Leading Individual Assignees
  • Table 16.39 Patent Analysis: Distribution of Patents by Age Since 2001
  • Table 16.40 Bioprocess Controllers and Automation Systems: Patent Valuation
  • Table 16.41 Overall Bioprocess Controllers and Automation Systems Market, Till 2035 (USD Million)
  • Table 16.42 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Controller (USD Million)
  • Table 16.43 Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, Till 2035 (USD Million)
  • Table 16.44 Bioprocess Controller and Automation Market for Bioprocess Control Software, Till 2035 (USD Million)
  • Table 16.45 Bioprocess Controller and Automation Market, Till 2035: Distribution by Scale of Operation (USD Million)
  • Table 16.46 Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, Till 2035 (USD Million)
  • Table 16.47 Bioprocess Controller and Automation Market for Commercial Operations, Till 2035 (USD Million)
  • Table 16.48 Bioprocess Controller and Automation Market, Till 2035: Distribution by Mode of Operation (USD Million)
  • Table 16.49 Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, Till 2035 (USD Million)
  • Table 16.50 Bioprocess Controller and Automation Market for Perfusion Manufacturing, Till 2035 (USD Million)
  • Table 16.51 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Bioprocessing Systems (USD Million)
  • Table 16.52 Bioprocess Controller and Automation Market for Single-use Systems, Till 2035 (USD Million)
  • Table 16.53 Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, Till 2035 (USD Million)
  • Table 16.54 Bioprocess Controller and Automation Market, Till 2035: Distribution by Key Geographical Regions (USD Million)
  • Table 16.55 Bioprocess Controller and Automation Market in North America, Till 2035 (USD Million)
  • Table 16.56 Bioprocess Controller and Automation Market in Europe, Till 2035 (USD Million)
  • Table 16.57 Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, Till 2035 (USD Million)

List of Figures

  • Figure 2.1 Executive Summary: Current Market Landscape of Upstream Controllers
  • Figure 2.2 Executive Summary: Current Market Landscape of Downstream Controller Systems
  • Figure 2.3 Executive Summary: Current Market Landscape of Bioprocess Control Software
  • Figure 2.4 Executive Summary: Patent Analysis
  • Figure 2.5 Executive Summary: Market Forecast and Opportunity Analysis
  • Figure 3.1 Factors Affecting Manufacturing Process of Biologics
  • Figure 3.2 Overview of Controlled Parameters in Bioreactors
  • Figure 3.3 Basic Bioprocess Control Model
  • Figure 3.4 Advantages of Bioprocess Automation
  • Figure 4.1 Upstream Controllers: Distribution by Scale of Operation
  • Figure 4.2 Upstream Controllers: Distribution by Key Features
  • Figure 4.3 Upstream Controllers: Distribution by Compatibility with Bioreactor systems
  • Figure 4.4 Upstream Controllers: Distribution by Mode of Operation
  • Figure 4.5 Upstream Controllers: Distribution by Types of Processes Controlled
  • Figure 4.6 Upstream Controller Developers: Distribution by Year of Establishment
  • Figure 4.7 Upstream Controller Developers: Distribution by Company Size
  • Figure 4.8 Upstream Controller Developers: Distribution by Location of Headquarters
  • Figure 4.9 Leading Developers: Distribution by Number of Products
  • Figure 5.1 Downstream Controller Systems: Distribution by Scale of Operation
  • Figure 5.2 Downstream controller systems: Distribution by Key Features
  • Figure 5.3 Downstream Controller Systems: Distribution by Type of Bioprocessing System(s)
  • Figure 5.4 Downstream Controller Systems: Distribution by Mode of Operation
  • Figure 5.5 Downstream Controller Systems: Distribution by Application Area
  • Figure 5.6 Downstream Controller System Developers: Distribution by Year of Establishment
  • Figure 5.7 Downstream Controller System Developers: Distribution by Company Size
  • Figure 5.8 Downstream Controller System Developers: Distribution by Location of Headquarters
  • Figure 5.9 Leading Developers: Distribution by Number of Products
  • Figure 6.1 Bioprocess Control Software: Distribution by Stage of Bioprocess
  • Figure 6.2 Bioprocess Control Software: Distribution by Scale of Operation
  • Figure 6.3 Bioprocess Control Software: Distribution by Key Features
  • Figure 6.4 Bioprocess Control Software: Distribution by Compatibility with Bioprocessing Systems
  • Figure 6.5 Bioprocess Control Software: Distribution by Types of Processes Controlled
  • Figure 6.6 Bioprocess Control Software Developers: Distribution by Year of Establishment
  • Figure 6.7 Bioprocess Control Software Developers: Distribution by Company Size
  • Figure 6.8 Bioprocess Control Software Developers: Distribution by Location of Headquarters
  • Figure 6.9 Leading Developers: Distribution by Number of Products
  • Figure 7.1 Product Competitiveness Analysis: Upstream Controllers
  • Figure 7.2 Product Competitiveness Analysis: Downstream Controller Systems (Chromatography Systems)
  • Figure 7.3 Product Competitiveness Analysis: Downstream Controller Systems (Tangential Flow Filtration Systems Systems)
  • Figure 7.4 Product Competitiveness Analysis: Bioprocess Control Software
  • Figure 10.1 World Map Representation: Distribution by Location of Headquarters and Type of Product(s) Offered
  • Figure 10.2 Heat Map Representation: Distribution by Scale of Operation, Compatibility with Bioreactor Systems and Mode of Operation
  • Figure 10.3 Grid Analysis: Distribution by Upstream Controllers by Scale of Operation, Compatibility with Bioreactor Systems and Types of Processes Controlled
  • Figure 10.4 Grid Analysis: Distribution by Scale of Operation, Type of Bioprocessing System(s) and Key Features
  • Figure 10.5 Downstream Controller System: Distribution by Mode of Operation and Application Area
  • Figure 10.6 Grid Analysis: Distribution by Scale of Operation, Key Features and Types of Processes Controlled
  • Figure 10.7 Bioprocess Control Software: Distribution by Scale of Operation and Compatibility with Bioprocessing Systems
  • Figure 11.1 Patent Analysis: Distribution by Type of Patent
  • Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, Since Pre-2015
  • Figure 11.3 Patent Analysis: Distribution by Application Year, Since Pre-2015
  • Figure 11.4 Patent Analysis: Distribution by Patent Office
  • Figure 11.5 Patent Analysis: Distribution by Geographical Location
  • Figure 11.6 Patent Analysis: Distribution by CPC Symbols
  • Figure 11.7 Patent Analysis: Emerging Focus Areas
  • Figure 11.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization
  • Figure 11.9 Patent Analysis: Leading Industry Players
  • Figure 11.10 Patent Analysis: Leading Non-Industry Players
  • Figure 11.11 Patent Analysis: Leading Individual Assignees
  • Figure 11.12 Patent Analysis (Leading Industry Players): Benchmarking by Patent Characteristics (CPC Symbols)
  • Figure 11.13 Patent Analysis: Distribution of Patents by Age Since 2001
  • Figure 11.14 Bioprocess Controllers and Automation Systems: Patent Valuation
  • Figure 12.1 Brand Positioning Analysis of Upstream Controller Developers: Competitive Advantage
  • Figure 12.2 Brand Positioning Analysis of Upstream Controller Developers: Reasons to Believe
  • Figure 12.3 Brand Positioning Matrix: Applikon Biotechnology
  • Figure 12.4 Brand Positioning Matrix: Eppendorf
  • Figure 12.5 Brand Positioning Matrix: Thermo Fisher Scientific
  • Figure 12.6 Brand Positioning Matrix: ILS Automation
  • Figure 12.7 Brand Positioning Matrix: Pierre Guerin
  • Figure 12.8 Brand Positioning Analysis of Downstream Controller System Developers: Competitive Advantage
  • Figure 12.9 Brand Positioning Analysis of Downstream Controller System Developers: Reasons to Believe
  • Figure 12.10 Brand Positioning Matrix: Cytiva
  • Figure 12.11 Brand Positioning Matrix: Sepragen
  • Figure 12.12 Brand Positioning Matrix: Merck Millipore
  • Figure 12.13 Brand Positioning Matrix: Sartorius Stedim Biotech
  • Figure 12.14 Brand Positioning Matrix: Repligen
  • Figure 12.15 Brand Positioning Matrix: Agilitech
  • Figure 12.16 Brand Positioning Analysis of Bioprocess Control Software Developers: Competitive Advantage
  • Figure 12.17 Brand Positioning Analysis of Bioprocess Control Software Developers: Reasons to Believe
  • Figure 12.18 Brand Positioning Matrix: Applikon Biotechnology
  • Figure 12.19 Brand Positioning Matrix: Pierre Guerin
  • Figure 12.20 Brand Positioning Matrix: Thermo Fisher Scientific
  • Figure 12.21 Brand Positioning Matrix: Merck Millipore
  • Figure 12.22 Brand Positioning Matrix: Sartorius Stedim Biotech
  • Figure 12.23 Brand Positioning Matrix: Cytiva
  • Figure 12.24 Brand Positioning Matrix: Bionet Engineering
  • Figure 13.1 Overall Bioprocess Controllers and Automation Systems Market, Till 2035 (USD Million)
  • Figure 13.2 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Controller (USD Million)
  • Figure 13.3 Bioprocess Controller and Automation Market for Upstream / Downstream Controller Systems, Till 2035 (USD Million)
  • Figure 13.4 Bioprocess Controller and Automation Market for Bioprocess Control Software, Till 2035 (USD Million)
  • Figure 13.5 Bioprocess Controller and Automation Market, Till 2035: Distribution by Scale of Operation (USD Million)
  • Figure 13.6 Bioprocess Controller and Automation Market for Preclinical / Clinical Operations, Till 2035 (USD Million)
  • Figure 13.7 Bioprocess Controller and Automation Market for Commercial Operations, Till 2035 (USD Million)
  • Figure 13.8 Bioprocess Controller and Automation Market, Till 2035: Distribution by Mode of Operation (USD Million)
  • Figure 13.9 Bioprocess Controller and Automation Market for Batch / Fed-batch Manufacturing, Till 2035 (USD Million)
  • Figure 13.10 Bioprocess Controller and Automation Market for Perfusion Manufacturing, Till 2035 (USD Million)
  • Figure 13.11 Bioprocess Controller and Automation Market, Till 2035: Distribution by Type of Bioprocessing Systems (USD Million)
  • Figure 13.12 Bioprocess Controller and Automation Market for Single-use Systems, Till 2035 (USD Million)
  • Figure 13.13 Bioprocess Controller and Automation Market for Stainless Steel / Other Systems, Till 2035 (USD Million)
  • Figure 13.14 Bioprocess Controller and Automation Market, Till 2035: Distribution by Key Geographical Regions (USD Million)
  • Figure 13.15 Bioprocess Controller and Automation Market in North America, Till 2035 (USD Million)
  • Figure 13.16 d (USD Million)
  • Figure 13.17 Bioprocess Controller and Automation Market in Asia-Pacific and Rest of the World, Till 2035 (USD Million)
  • Figure 14.1 Concluding Remarks: Current Market Landscape of Upstream Controllers
  • Figure 14.2 Concluding Remarks: Current Market Landscape of Downstream Controller Systems
  • Figure 14.3 Concluding Remarks: Current Market Landscape of Bioprocess Control Software
  • Figure 14.4 Concluding Remarks: Patent Analysis
  • Figure 14.5 Concluding Remarks: Market Forecast and Opportunity Analysis